Succinylcholine is one of the most commonly used drugs by anesthesiologists worldwide for rapid access to airway both in emergency and elective situations. Nonetheless, the very mention of succinylcholine generates the most energetic high decibel debate between its users and nonusers. Despite its potential to produce a short-acting, ultra-intense neuromuscular block rapidly in seconds, it is surrounded by a plethora of side effects and drug interactions. This case report is about one such drug interaction of this innocent yet malicious drug, which resulted in the death of a 14-year-old girl. Both β-adrenergic blockers and succinylcholine are known to cause hyperkalemia. Life-threatening hyperkalemia in susceptible individuals who have been administered succinylcholine has the most severe effect on the myocardium and can result in asystole with minimal chances of resuscitation. Both succinylcholine and a nonselective β-adrenergic blocker, propranolol, have the propensity to affect the transcellular redistribution of potassium which can result in hyperkalemia. We advocate cautious use of this drug combination till further studies confirm the drug interaction and find the potential triggering factors involved.
Frontometaphyseal dysplasia (FMD), also called Gorlin-Cohen syndrome, is a rare hereditary X-linked dominant craniotubular bone disorder. The presentation describes the airway management of a 2-year-old child suffering from FMD with significant retrognathia, posted for major long bone corrective osteotomy. Induction with a combination of dexmedetomidine and ketamine preceded a successful endotracheal intubation under spontaneous ventilation.
BACKGROUND Scoliosis, a major surgery conducted under general anaesthesia causes significant neuroendocrine stress response. Conduct of the wake-up test may further exaggerate the stress response due to the uncomfortable prone position during surgery and also presence of an endotracheal tube in situ during conduct of the test. Dexmedetomidine causes modulation of catecholamine release, which minimises the neuroendocrine and haemodynamic stress response. MATERIALS AND METHODS50 cases of NF-1 coming for scoliosis repair were studied over 4 years prospectively for quality of wake-up test, control of blood loss and haemodynamic stability due to administration of Dexmedetomidine infusion. Dexmedetomidine was started intravenously as a bolus 1 ug/ kg over 10 minutes followed by 1 ug/ kg/ hour infusion. HR, ECG, SpO2, IABP, temperature and urine output was monitored. Wake-up test: Surgeons requested for wake-up test half an hour in advance. Atracurium infusion was stopped. Isoflurane was stopped 15 mins later. Dexmedetomidine was continued at 0.5 µg/ kg/ hr. Study Design-Descriptive Study. RESULTSIn our study, we did not see any of these complications and all 50 patients had good quality of wake-up test. The patients were calm due to the hypnotic and anxiolytic actions of dexmedetomidine. They responded to commands equivalent to a Ramsay sedation scale of 2. They were pain free, haemodynamically stable with good spontaneous respiration. Intraoperative period was characterised by haemodynamic stability (Heart rate was maintained between 80 -120/mins, ABP-70/ 40 -100/ 60 mmHg, P-max 20 -24 mmHg). Average blood loss was around 15 mL/kg body weight. Major blood loss requiring massive blood transfusion was not seen; 1 unit of packed cells was transfused in each of the 50 cases. CONCLUSIONIntraoperative dexmedetomidine use has multiple advantages in NF-1 patients undergoing scoliosis corrective surgery. A randomised controlled study is necessary to statistically evaluate the multiple benefits of dexmedetomidine.
BACKGROUNDIn adults, extraperitoneal lower abdominal and lower limb procedures are performed under epidural or spinal anaesthesia without supplemental general anaesthesia. However, similar procedures in paediatric population to be performed under regional anaesthesia require additional sedation, analgesia to immobilise the child during institution of the regional anaesthetic technique and continued sedation during the surgical procedure to ensure cooperation of the child. Aims and Objectives-To evaluate the efficacy and safety of a combination of intravenous infusion of dexmedetomidine and fentanyl for sedation during surgeries done under regional anaesthesia in children. MATERIALS AND METHODS22 children, ranging in age from 2 to 12 years of both sexes posted for lower limb deformity correction, lower abdominal, extraperitoneal and hypospadias repair were selected continuously for this study. Sample size since there were no previous similar studies, we selected continuously all patients who met the eligibility criteria during the study period. Pharmacological Interventions: Intravenous access was secured and the loading dose of intravenous Dexmedetomidine and Fentanyl, both at the rate of 1 ug/kg /hr was infused over 10 minutes using a syringe pump. At the end of 10 minutes, a maintenance dose of 1 ug/kg of the same was continued. Lumbar epidural catheter was inserted using 19-G epidural Tuohy needle (PORTEX) and 0.5% Bupivacaine 0.5 mL/kg up to a maximum dose of 2.5 mg/kg was deposited and the catheter was secured. Surgical procedure was conducted with the child breathing spontaneously with supplementation of oxygen 3 L/minute through a face mask. Inj. Propofol 1mg/kg was used as rescue sedation. The perioperative monitoring to evaluate the efficacy of sedation under the study regimen and need to opt for rescue sedation included ECG, Heart rate, NIBP, SPO2, EtCO2, the Respiratory rate, level of sedation and time to achieve Ramsay score of 2 in recovery room. Design-Descriptive. Setting-250 bedded paediatric referral hospital offering tertiary care to South Asian population. RESULTSEffective sedation in all 22 patients was achieved intraoperatively with intravenous infusion of Fentanyl 1 ug/kg/hour and Dexmedetomidine 1 ug/kg/hour combined with epidural block with Bupivacaine 0.5%. Primary outcome measured was the need for rescue sedation which was required in 3 out of 22 cases, i.e. 13.6%. The vital parameters were as follows. The maximum change in mean heart rate from baseline was during the intraoperative period (P4), being 28.4 ± 28.7 (p < 0.001). The lowest recorded value was 58/m. Blood pressure changes showed a maximum mean change from baseline seen in both the systolic as well as diastolic pressures at the end of 10 minutes of bolus and was -7.7 ± 18 and -7.8 ± 16 mmHg. No patient's respiratory rate decreased to less than 12 breaths/min or increased above 28 breaths/min during the procedural sedation. The highest EtCO2 was 30 mmHg. Oxygen saturation remained between 97 to 100% during the study in all pati...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.